Vimta Labs Q4 Results
- BSE: 524394
- NSE: VIMTALABS
- ISIN: INE579C01029
- Sector: Biotechnology & Drugs
BSE
615.55
-16.90 (-2.67%)
-16.90 (-2.67%)Volume6.33 K
Updated: Fri 14 Aug, 2026 | 15:29:49
NSE
618-15.20 (-2.40%)
-15.20 (-2.40%)Volume1.26 L
Updated: Fri 14 Aug, 2026 | 15:29:59
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q4 Results Highlights
Quarter ended Mar 26
Note: Comparison is on QoQ basis
Quarterly - Vimta Labs Q4 Results
*All figures in crores except per share values
| Fiscal Period | Mar 26 | Dec 25 | QoQ Comp | Mar 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 82.63 | 76.94 | 7.40% | 54.65 | 17.01% |
| Depreciation/ Amortization | 12.75 | 10.92 | 16.78% | 7.84 | 38.42% |
| Operating Income | 26.62 | 21.70 | 22.68% | 18.08 | 11.72% |
| Net Income | 21.11 | 17.59 | 20.06% | 12.35 | 15.25% |
| Other Operating Expenses Total | 17.83 | 16.63 | 7.20% | 8.36 | 39.51% |
| Net Income Before Taxes | 29.05 | 23.37 | 24.29% | 17.94 | 16.06% |
| Total Revenue | 109.25 | 98.63 | 10.76% | 72.73 | 15.68% |
| Selling/ General/ Admin Expenses Total | 29.57 | 28.41 | 4.10% | 25.08 | -2.87% |
| Diluted Normalized EPS | 4.61 | 4.21 | 9.52% | 3.02 | 14.41% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.